[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"kartagener-syndrome\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:kartagener-syndrome":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,42,62],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":25,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100118401","pathogenesis-of-primary-ciliary-dyskinesia-pcd-lung-disease-100118401",false,"NCT00807482","Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease","Diagnostic and Clinical Characterization of Patients With Unusual Genetic Disorders of the Airways","Inclusion Criteria:\n\n* Patients who have a high suspicion for the diagnosis of PCD, based on clinical features\n\nHealthy Volunteers who have a family member with confirmed PCD.",true,"ALL",{"count":19,"type":20},1800,"ESTIMATED","OBSERVATIONAL","The overall short-term goals of this project include the following: 1) identify the genes that are key to the function of respiratory cilia to protect the normal lung; and 2) the effects of genetic mutations that adversely affect ciliary function and cause primary ciliary dyskinesia (PCD), which results in life-shortening lung disease. The long-term goal of this project is to develop better understanding of the underlying genetic variability that adversely modifies ciliary function, and predisposes to common airway diseases, such as asthma and chronic obstructive pulmonary disease.",[24],"Kartagener Syndrome",[26,27,28],"Primary Ciliary Dyskinesia","Mucociliary Clearance","Genetic Mutation","RECRUITING","2026-06-24",{"date":32,"type":33},"2026-06-29","ACTUAL",{"date":35,"type":4},"2004-01",{"date":37,"type":20},"2027-06",{"name":39,"class":40},"University of North Carolina, Chapel Hill","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":49,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":51,"conditions":52,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":41},"100409440","the-ear-nose-throat-ent-prospective-international-cohort-of-pcd-patients-epic-pcd-100409440","NCT04611516","The Ear-Nose-Throat (ENT) Prospective International Cohort of PCD Patients (EPIC-PCD)","EPIC-PCD","Inclusion Criteria:\n\n* Diagnosis of PCD (clinical and test certified)\n* Patient must undergo an ENT examination minimum once a year as part of their clinical follow-up\n\nExclusion Criteria:\n\nNone",{"count":50,"type":20},1000,"The Ear-Nose-Throat (ENT) Prospective International Cohort of patients with Primary Ciliary Dyskinesia (EPIC-PCD) is a prospective observational clinical cohort study, set up as a multinational multi-centre study. It is embedded into routine patient care of participating reference centres for PCD and patients keep being managed according to local procedures and guidelines.",[26,24],"2025-11-24",{"date":55,"type":33},"2025-12-02",{"date":57,"type":33},"2020-03-02",{"date":59,"type":20},"2040-12",{"name":61,"class":40},"University of Bern",{"id":63,"slug":64,"hasResults":11,"nctId":65,"briefTitle":66,"officialTitle":66,"acronym":67,"eligibilityCriteria":68,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":69,"targetDuration":71,"studyType":21,"phases":4,"briefSummary":72,"conditions":73,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":74,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":41},"100332278","swiss-primary-ciliary-dyskinesia-registry-100332278","NCT03606200","Swiss Primary Ciliary Dyskinesia Registry","CH-PCD","Inclusion Criteria:\n\n* Patients diagnosed with primary ciliary dyskinesia\n* Signed informed consent or assent\n\nExclusion Criteria:\n\n\\-",{"count":70,"type":20},800,"80 Years","The Swiss Primary Ciliary Dyskinesia (PCD) Registry is a national patient registry that collects information on diagnosis, symptoms, treatment and follow-up of patients with PCD in Switzerland and provides data for national and international monitoring and research.",[26,24],{"date":75,"type":33},"2025-11-25",{"date":77,"type":33},"2013-01",{"date":79,"type":20},"2080-12",{"name":61,"class":40}]